What is Emulait?
Founded in 2019 and headquartered in Las Vegas, Nevada, Emulait has developed the first baby feeding system engineered to replicate the breastfeeding experience. Through four years of dedicated research, the integration of seven patented technologies, advanced 3D scanning, and the use of FDA-approved medical-grade materials, Emulait's product meticulously mimics the shape, color, elasticity, texture, and feel of a mother's breast. This innovation aims to bridge the perceived gap between bottle and breast feeding, offering an unparalleled feeding experience for infants.
How much funding has Emulait raised?
Emulait has raised a total of $14M across 2 funding rounds:
Series A
$11M
Private Equity
$3M
Series A (2023): $11M, investors not publicly disclosed
Private Equity (2025): $3M, investors not publicly disclosed
What's next for Emulait?
The substantial enterprise-level backing Emulait has received, particularly the recent strategic investment, positions the company for accelerated scaling and market penetration. This financing is expected to fuel further research and development, enhance manufacturing capabilities, and expand its commercial reach. Emulait's focus on a critical aspect of infant care, combined with its proprietary technology, suggests a strong trajectory for growth and market leadership in the baby product sector. The company's commitment to innovation and its unique product offering are key drivers for its future success.
See full Emulait company page
